查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1916505

全球合约研究组织 (CRO) 服务市场：市场规模、份额、成长率、行业分析、按类型、应用和地区划分的考虑因素以及未来预测 (2026-2034)

Contract Research Organization Services Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 168 Pages | 商品交期: 请询问到货日

价格

合约研究组织 (CRO) 服务市场成长因素

预计全球合约研究组织 (CRO) 服务市场规模在 2025 年将达到 922.7 亿美元，2026 年将成长至 998.7 亿美元，并在 2034 年达到 1992.8 亿美元。预计在预测期内（2026-2034 年），其复合年增长率 (CAGR) 为 9%。北美地区在 2025 年将以 50.10% 的市场份额引领 CRO 服务市场，这得益于主要 CRO 公司的强大实力、活跃的临床试验活动以及大规模的药物研发投资。

合约研究组织 (CRO) 为製药、生物技术和医疗器材公司提供外包研究服务，包括早期开发、临床试验、实验室检测、法规支援和资料管理。研发活动外包的日益增多以及药物研发流程的日益复杂性是推动市场稳定扩张的关键因素。

市场驱动因素

全球临床试验数量的不断增长是推动 CRO 服务需求的主要因素。根据世界卫生组织 (WHO) 统计，到 2024 年，全球註册的临床试验数量将达到 38,788 项，较 2010 年的 28,432 项显着增长，显示研究活动正在扩大。药物研发成本仍然非常高昂，据估计，每项临床试验的平均成本为：I 期 400 万美元，II 期 1,300 万美元，III 期 2,000 万美元。此外，只有 12% 的候选药物能够进入临床试验阶段并获得监管部门的批准，因此，将临床试验外包给合约研究组织 (CRO) 是一种经济高效且降低风险的策略，尤其对于中小生物製药公司而言更是如此。

CRO 与生技公司之间的合作持续成长。 2024 年 11 月，诺沃泰克与北京百奥斯达药业合作，以加强其临床开发项目，凸显了全球合作加速研发进程的趋势。

市场限制因子

严格且具地域性的监管架构为 CRO 的营运带来了挑战。伦理审批、试验中心审批和病患招募的监管延误会延缓试验启动，并增加营运复杂性。根据美国国家生物技术资讯中心 (NCBI) 发表的一项研究，监管延误是临床试验时间延长和招募困难的主要原因之一，限制了多国试验的快速发展。

市场机会

在先天性异常和围产期疾病等研究不足的治疗领域进行新研究，蕴藏着巨大的未来机会。根据世界卫生组织的数据，到2024年，针对先天性异常的临床试验仅有328项，而针对恶性肿瘤的临床试验则高达5,306项，显示该领域的研究潜力尚未充分开发。预计资金投入的增加和跨境合作将扩大合约研究组织（CRO）在这些专业领域的参与度。 2021年3月，Natera公司与Tesis Labs合作，以增强其基因检测能力，这反映了市场对专业诊断研究服务日益增长的需求。

市场挑战

区域监管差异增加了合规成本，并要求CRO保持多元化的监管专业知识。日益严峻的网路安全威胁也因更严格的资料保护法律而限制了病患参与临床试验。此外，熟练的临床研究专业人员短缺和基础设施成本不断上涨，也增加了CRO供应商的服务交付成本和营运风险。

CRO服务市场趋势

研发支出不断成长，推动了临床试验外包。根据欧洲製药工业协会联合会（EFPIA）统计，2022年製药业的研发支出将达到467.928亿美元，比前一年成长7.2%。企业越来越依赖CRO来管理复杂的试验、罕见疾病研究、肿瘤计画和上市后监测。

人工智慧和机器学习工具正被用于优化病患招募、方案设计、预测分析和试验监查。利用远距监查、穿戴式装置和数位平台的去中心化临床试验也越来越普遍，这有助于提高病患参与率并降低试验中心成本。基因组分析和生物标记研究为个人化医疗的发展提供了支持，进一步推动了对专业CRO服务的需求。

依细分市场分析

按类型

市场细分为早期研发服务、临床服务、检测服务及其他服务。早期研发服务是市场成长的主要驱动力，这主要得益于对药物发现、临床前测试以及化学、生产和控制 (CMC) 服务的日益重视。临床服务（包括I期至IV期临床试验）预计将实现强劲成长，主要得益于中后期研发管线的扩展。

按应用领域

肿瘤学在应用领域中占据最大的市场份额，这主要得益于癌症发生率的上升和不断扩大的抗癌药物研发管线。预计2023年美国将新增1,958,310例癌症病例，反映出癌症临床试验的持续需求。由于阿兹海默症和神经退化性疾病的盛行率不断上升，神经病学领域预计将保持稳定成长。传染病和代谢性疾病的研究也推动了临床试验数量的增加。

依最终使用者划分

由于研发管线日益复杂以及研发阶段外包的增加，製药和生技公司占据了最大的市场份额。在註册的医疗器材临床试验数量不断增加的推动下，医疗器材製造商预计将以更快的速度成长。

依地区划分

北美将在2026年以498.8亿美元的市场规模引领市场，其中美国占447.8亿美元。全球约30%的临床试验在美国註册。欧洲将在2026年以257.7亿美元的市场规模位居第二，这得益于强劲的製药研发投资。亚太地区是成长最快的地区，预计到2026年将达到194.5亿美元，这主要得益于成本优势、製造能力的提升以及与合约研究组织（CRO）合作的拓展。其中，中国预计将占56.9亿美元，印度占38.6亿美元，日本占35亿美元。

目录

第一章：引言

第二章：执行摘要

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家和地区临床试验数量（2025 年）
  • 临床试验分布（2025 年）
  • 概述：CRO（合约研究组织）服务市场的新兴公司与创新
  • 关键趋势：併购、合作等

章节5：全球合约研究组织 (CRO) 服务市场分析：洞察与预测 (2021-2034)

  • 市场分析、洞察与预测：依类型划分
    • 早期开发服务
      • 化学、生产和控制 (CMC)
      • 临床前服务
      • 药物发现
    • 临床服务
      • I期临床试验
      • II期临床试验
      • III期临床试验
      • IV期临床试验
    • 实验室服务
    • 其他
  • 市场分析、洞察与预测：依应用划分
    • 肿瘤学
    • 神经系统疾病
    • 心臟病学
    • 传染病
    • 代谢性疾病疾病
    • 神经病学/肾臟病学
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 製药和生技公司
    • 医疗器材製造商
    • 学术和研究机构
    • 其他
  • 市场分析、洞察与预测：按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区 (ROW)

第六章：北美合约研究组织 (CRO) 服务市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲合约研究组织 (CRO)亚太地区合约研究组织 (CRO) 服务市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区合约研究组织 (CRO) 服务市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 东南亚
    • 亚太其他地区

第九章 世界其他地区 (ROW) 合约研究组织 (CRO) 服务市场分析：洞察与预测（2021-2034）

第10章 竞争分析

  • 世界市场占有率分析(2025年)
  • 企业简介
    • Medpace
    • Laboratory Corporation of America Holdings
    • ICON plc
    • IQVIA Inc
    • Syneos Health
    • Novotech
    • KCR S.A.
    • PSI
    • Ergomed Group
    • Thermo Fisher Scientific Inc.
    • WuXi Biologics
    • Tigermed
    • Worldwide Clinical Trials
    • Charles River Laboratories
    • Microbiologics
    • Parexel International(MA)Corporation
Product Code: FBI100864

Growth Factors of Contract Research Organization (CRO) services Market

The global Contract Research Organization (CRO) services market size was valued at USD 92.27 billion in 2025 and is projected to grow to USD 99.87 billion in 2026, reaching USD 199.28 billion by 2034, expanding at a CAGR of 9% during the forecast period (2026-2034). North America dominated the CRO services market with a 50.10% market share in 2025, supported by a strong presence of large CRO firms, high clinical trial activity, and substantial pharmaceutical R&D investments.

Contract Research Organizations provide outsourced research services including early-phase development, clinical trials, laboratory testing, regulatory support, and data management to pharmaceutical, biotechnology, and medical device companies. Increasing outsourcing of R&D activities and rising complexity of drug development pipelines are major contributors to the market's steady expansion.

Market Drivers

The growing number of clinical trials globally is a primary driver of CRO services demand. According to the World Health Organization, 38,788 clinical trials were registered worldwide in 2024, rising significantly from 28,432 trials in 2010, indicating expanding research activity. Drug development remains highly expensive, with average clinical phase costs estimated at USD 4.0 million for Phase I, USD 13.0 million for Phase II, and USD 20.0 million for Phase III. Furthermore, only 12% of drug candidates entering clinical trials receive regulatory approval, making outsourcing to CROs a cost-efficient and risk-reducing strategy, especially for small and mid-sized biopharmaceutical firms.

Partnerships between CROs and biotech companies continue to increase. In November 2024, Novotech partnered with Beijing Biostar Pharmaceuticals to strengthen clinical development programs, highlighting the growing trend of global collaborations to accelerate development timelines.

Market Restraints

Stringent and region-specific regulatory frameworks pose challenges for CRO operations. Regulatory delays in ethical approvals, site authorization, and patient recruitment slow trial initiation and increase operational complexity. According to research published by NCBI, regulatory delays are among the primary reasons for postponed clinical study timelines and recruitment difficulties, limiting faster execution of trials across multiple countries.

Market Opportunities

Emerging research in under-studied therapeutic areas such as congenital anomalies and perinatal conditions offers strong future opportunities. WHO data shows that in 2024, only 328 clinical trials targeted congenital anomalies, compared to 5,306 trials for malignant neoplasms, indicating untapped research segments. Increasing funding and cross-border collaborations are expected to expand CRO involvement in these specialized areas. In March 2021, Natera Inc. collaborated with Tesis Labs to enhance genetic testing capabilities, reflecting rising demand for specialized diagnostic research services.

Market Challenges

Regulatory heterogeneity across regions increases compliance costs and requires CROs to maintain diverse regulatory expertise. Rising cybersecurity threats also restrict patient participation in trials due to stricter data protection laws. Additionally, shortages of skilled clinical research professionals and growing infrastructure costs increase service delivery expenses and operational risks for CRO providers.

CRO Services Market Trends

Outsourcing of clinical trials continues to rise due to escalating R&D expenditure. According to EFPIA, pharmaceutical R&D spending reached USD 46,792.8 million in 2022, showing a 7.2% increase year-on-year. Companies increasingly rely on CROs to manage complex trials, rare disease research, oncology programs, and post-marketing surveillance studies.

AI and machine learning tools are being adopted for patient recruitment optimization, protocol design, predictive analytics, and trial monitoring. Decentralized clinical trials using remote monitoring, wearable devices, and digital platforms are also gaining adoption, improving patient participation and lowering site costs. Personalized medicine research supported by genomic and biomarker-based studies further increases demand for specialized CRO services.

Segmentation Analysis

By Type

The market is segmented into early phase development services, clinical services, laboratory services, and others. Early phase development services dominated the market, driven by increased focus on discovery, preclinical studies, and Chemistry, Manufacturing, and Controls (CMC) services. The clinical services segment, including Phase I-IV trials, is expected to witness strong growth due to expanding mid-stage and late-stage pipelines.

By Application

Oncology dominated application segments due to rising cancer incidence and increasing oncology drug pipelines. In the U.S., 1,958,310 new cancer cases were reported in 2023, reflecting continuous need for oncology trials. Neurology is expected to grow steadily due to increasing prevalence of Alzheimer's disease and neurodegenerative disorders, while infectious disease and metabolic disorder research also contributes to trial volume growth.

By End-User

Pharmaceutical and biotechnology companies accounted for the largest share due to rising pipeline complexity and increasing outsourcing of development stages. Medical device companies are expected to grow at a faster pace, supported by rising numbers of registered device-based clinical trials.

Regional Outlook

North America led the market with USD 49.88 billion in 2026, supported by the U.S. accounting for USD 44.78 billion in 2026. Approximately 30% of all global clinical trials are registered in the U.S. Europe ranked second with USD 25.77 billion in 2026, supported by strong pharmaceutical R&D investment. Asia Pacific is the fastest-growing region, valued at USD 19.45 billion in 2026, driven by cost advantages, rising manufacturing capabilities, and expanding CRO partnerships. China reached USD 5.69 billion, India USD 3.86 billion, and Japan USD 3.50 billion in 2026.

Competitive Landscape

Key players including IQVIA, ICON plc, Syneos Health, Charles River Laboratories, Parexel, Thermo Fisher Scientific, Medpace, and Fortrea focus on service expansion, digital integration, and global delivery models. Strategic partnerships, acquisitions, and technology investments remain central strategies for market positioning and long-term service scalability.

Conclusion

The Contract Research Organization (CRO) services market is positioned for strong long-term expansion, growing from USD 92.27 billion in 2025 to USD 99.87 billion in 2026, and further reaching USD 199.28 billion by 2034, supported by a 9% CAGR during 2026-2034. Market growth is driven by the rising number of global clinical trials, increasing R&D costs, low drug approval success rates, and the growing reliance of pharmaceutical, biotechnology, and medical device companies on outsourced research models. North America continues to lead with a 50.10% share in 2025, while Asia Pacific shows the fastest growth momentum due to cost efficiencies and expanding research infrastructure. Technological adoption such as AI-driven trial management, decentralized clinical trials, and personalized medicine research is reshaping service delivery models, while regulatory complexity and workforce shortages remain key operational challenges. Overall, CROs are becoming integral partners across the drug and device development lifecycle, playing a critical role in accelerating innovation, improving trial efficiency, and supporting global therapeutic advancement.

Segmentation By Type

  • Early Phase Development Services
    • Chemistry, Manufacturing and Controls (CMC)
    • Preclinical Service
    • Discovery
  • Clinical
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • Laboratory Services
  • Others

By Application

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Disease
  • Metabolic Disorder
  • Renal/Nephrology
  • Others

By End-user

  • Pharmaceutical & Biotechnological Companies
  • Medical Device Companies
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-user, and Country/Country-Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-user, and Country/Country-Sub-region )
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Rest of the World (By Type, Application, and End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Clinical Trials Conducted by Key Countries/ Regions, 2025
  • 4.2. Distribution of Clinical Trials, 2025
  • 4.3. Overview: Start-ups and Innovations in the Contract Research Organization (CRO) Services Market
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Early Phase Development Services
      • 5.1.1.1. Chemistry, Manufacturing and Controls (CMC)
      • 5.1.1.2. Preclinical Services
      • 5.1.1.3. Discovery
    • 5.1.2. Clinical
      • 5.1.2.1. Phase 1
      • 5.1.2.2. Phase 2
      • 5.1.2.3. Phase 3
      • 5.1.2.4. Phase 4
    • 5.1.3. Laboratory Services
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Oncology
    • 5.2.2. Neurology
    • 5.2.3. Cardiology
    • 5.2.4. Infectious Disease
    • 5.2.5. Metabolic Disorders
    • 5.2.6. Renal/Nephrology
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Pharmaceutical & Biotechnological Companies
    • 5.3.2. Medical Device Companies
    • 5.3.3. Academic & Research Institutes
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Early Phase Development Services
      • 6.1.1.1. Chemistry, Manufacturing and Controls (CMC)
      • 6.1.1.2. Preclinical Services
      • 6.1.1.3. Discovery
    • 6.1.2. Clinical
      • 6.1.2.1. Phase 1
      • 6.1.2.2. Phase 2
      • 6.1.2.3. Phase 3
      • 6.1.2.4. Phase 4
    • 6.1.3. Laboratory Services
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Oncology
    • 6.2.2. Neurology
    • 6.2.3. Cardiology
    • 6.2.4. Infectious Disease
    • 6.2.5. Metabolic Disorders
    • 6.2.6. Renal/Nephrology
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Pharmaceutical & Biotechnological Companies
    • 6.3.2. Medical Device Companies
    • 6.3.3. Academic & Research Institutes
    • 6.3.4. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Early Phase Development Services
      • 7.1.1.1. Chemistry, Manufacturing and Controls (CMC)
      • 7.1.1.2. Preclinical Services
      • 7.1.1.3. Discovery
    • 7.1.2. Clinical
      • 7.1.2.1. Phase 1
      • 7.1.2.2. Phase 2
      • 7.1.2.3. Phase 3
      • 7.1.2.4. Phase 4
    • 7.1.3. Laboratory Services
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Oncology
    • 7.2.2. Neurology
    • 7.2.3. Cardiology
    • 7.2.4. Infectious Disease
    • 7.2.5. Metabolic Disorders
    • 7.2.6. Renal/Nephrology
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Pharmaceutical & Biotechnological Companies
    • 7.3.2. Medical Device Companies
    • 7.3.3. Academic & Research Institutes
    • 7.3.4. Others
  • 7.4. Market Analysis - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia pacific Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Early Phase Development Services
      • 8.1.1.1. Chemistry, Manufacturing and Controls (CMC)
      • 8.1.1.2. Preclinical Services
      • 8.1.1.3. Discovery
    • 8.1.2. Clinical
      • 8.1.2.1. Phase 1
      • 8.1.2.2. Phase 2
      • 8.1.2.3. Phase 3
      • 8.1.2.4. Phase 4
    • 8.1.3. Laboratory Services
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Oncology
    • 8.2.2. Neurology
    • 8.2.3. Cardiology
    • 8.2.4. Infectious Disease
    • 8.2.5. Metabolic Disorders
    • 8.2.6. Renal/Nephrology
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Pharmaceutical & Biotechnological Companies
    • 8.3.2. Medical Device Companies
    • 8.3.3. Academic & Research Institutes
    • 8.3.4. Others
  • 8.4. Market Analysis - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. South Korea
    • 8.4.6. Southeast Asia
    • 8.4.7. Rest of Asia Pacific

9. Rest of the World Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Early Phase Development Services
      • 9.1.1.1. Chemistry, Manufacturing and Controls (CMC)
      • 9.1.1.2. Preclinical Services
      • 9.1.1.3. Discovery
    • 9.1.2. Clinical
      • 9.1.2.1. Phase 1
      • 9.1.2.2. Phase 2
      • 9.1.2.3. Phase 3
      • 9.1.2.4. Phase 4
    • 9.1.3. Laboratory Services
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Oncology
    • 9.2.2. Neurology
    • 9.2.3. Cardiology
    • 9.2.4. Infectious Disease
    • 9.2.5. Metabolic Disorders
    • 9.2.6. Renal/Nephrology
    • 9.2.7. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Pharmaceutical & Biotechnological Companies
    • 9.3.2. Medical Device Companies
    • 9.3.3. Academic & Research Institutes
    • 9.3.4. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Medpace
    • 10.2.2. Laboratory Corporation of America Holdings
    • 10.2.3. ICON plc
    • 10.2.4. IQVIA Inc
    • 10.2.5. Syneos Health
    • 10.2.6. Novotech
    • 10.2.7. KCR S.A.
    • 10.2.8. PSI
    • 10.2.9. Ergomed Group
    • 10.2.10. Thermo Fisher Scientific Inc.
    • 10.2.11. WuXi Biologics
    • 10.2.12. Tigermed
    • 10.2.13. Worldwide Clinical Trials
    • 10.2.14. Charles River Laboratories
    • 10.2.15. Microbiologics
    • 10.2.16. Parexel International (MA) Corporation

List of Tables

  • Table 1: Global Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Early Phase Development Services, 2021-2034
  • Table 3: Global CRO ServiicesMarket Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 4: Global Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8: North America Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Early Phase Development Services, 2021-2034
  • Table 9: North America Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 10: North America Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Europe Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Early Phase Development Services, 2021-2034
  • Table 15: Europe Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 16: Europe Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 18: Europe Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20: Asia Pacific Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Early Phase Development Services, 2021-2034
  • Table 21: Asia Pacific Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 22: Asia Pacific Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Rest of the World Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Rest of the World Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Early Phase Developmnt Services, 2021-2034
  • Table 27: Rest of the World Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Clinical, 2021-2034
  • Table 28: Rest of the World Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Rest of the World Contract Research Organization (CRO) Services Market Revenue (USD billion) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Contract Research Organization (CRO) Services Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Contract Research Organization (CRO) Services Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Contract Research Organization (CRO) Services Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Contract Research Organization (CRO) Services Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Contract Research Organization (CRO) Services Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Contract Research Organization (CRO) Services Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Contract Research Organization (CRO) Services Market Value Share (%), by Type, 2025
  • Figure 8: North America Contract Research Organization (CRO) Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Contract Research Organization (CRO) Services Market Value Share (%), by Application, 2025
  • Figure 10: North America Contract Research Organization (CRO) Services Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Contract Research Organization (CRO) Services Market Value Share (%), by End-user, 2025
  • Figure 12: North America Contract Research Organization (CRO) Services Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Contract Research Organization (CRO) Services Market Value Share (%), By Country, 2025
  • Figure 14: Europe Contract Research Organization (CRO) Services Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Contract Research Organization (CRO) Services Market Value Share (%), by Type, 2025
  • Figure 16: Europe Contract Research Organization (CRO) Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Contract Research Organization (CRO) Services Market Value Share (%), by Application, 2025
  • Figure 18: Europe Contract Research Organization (CRO) Services Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Contract Research Organization (CRO) Services Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Contract Research Organization (CRO) Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Contract Research Organization (CRO) Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Contract Research Organization (CRO) Services Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Contract Research Organization (CRO) Services Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Contract Research Organization (CRO) Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Contract Research Organization (CRO) Services Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Contract Research Organization (CRO) Services Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Contract Research Organization (CRO) Services Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Contract Research Organization (CRO) Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Contract Research Organization (CRO) Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Rest of the World Contract Research Organization (CRO) Services Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Rest of the World Contract Research Organization (CRO) Services Market Value Share (%), by Type, 2025
  • Figure 32: Rest of the World Contract Research Organization (CRO) Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Rest of the World Contract Research Organization (CRO) Services Market Value Share (%), by Application, 2025
  • Figure 34: Rest of the World Contract Research Organization (CRO) Services Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Rest of the World Contract Research Organization (CRO) Services Market Value Share (%), by End-user, 2025
  • Figure 36: Global Contract Research Organization (CRO) Services Market Share (%), By Company, 2025